FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”
In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI
It’s Official – UCLA Recognize As 19th Comprehensive Center
FDA Committee to Discuss Policy On Combinations
L.A. County Nears Crucial Decision On Construction Funds
Swiss Report On Radiotherapy Mortality Questioned
ACCC To Consider Cancer Act Changes HSA Problems
New Atlas Showing nonwhite Mortality Rates Available
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









